CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation

References

• Korean Network for Organ Sharing (KONOS)2016 Annals of Transplantation Statistics SeoulKoreaKorean Network for Organ Sharing, Korea Centers for Disease Control & Prevention2017
   Google Scholar
• KimWRLakeJRSmithJMOPTN/SRTR 2016 Annual Data Report: LiverAm J Transplant201818Suppl 117225329292603
   PubMed Web of Science ®Google Scholar
• JiEChoiLSuhKSChoJYHanNOhJMCombinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantationTransplantation201294886687222992768
   PubMed Web of Science ®Google Scholar
• LuceyMRTerraultNOjoLLong-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationLiver Transpl201319132623281277
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL Clinical Practice Guidelines: Liver transplantationJ Hepatol201664243348526597456
   PubMed Web of Science ®Google Scholar
• ShukerNvan GelderTHesselinkDAIntra-patient variability in tacrolimus exposure: causes, consequences for clinical managementTransplant Rev20152927884
   Web of Science ®Google Scholar
• StaatzCETettSEClinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantationClin Pharmacokinet2004431062365315244495
   PubMed Web of Science ®Google Scholar
• ScottLJMckeageKKeamSJPloskerGLTacrolimus: a further update of its use in the management of organ transplantationDrugs200363121247129712790696
   PubMed Web of Science ®Google Scholar
• JuskoWJThomsonAWFungJConsensus document: therapeutic monitoring of tacrolimus (FK-506)Ther Drug Monit19951766066148588229
   PubMed Web of Science ®Google Scholar
• WallemacqPArmstrongVWBrunetMOpportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conferenceTher Drug Monit200931213915219177031
   PubMed Web of Science ®Google Scholar
• BrooksETettSEIsbelNMStaatzCEPopulation Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Clin Pharmacokinet201655111295133527138787
   PubMed Web of Science ®Google Scholar
• LeeJYHahnHJSonIJFactors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipientsPharmacotherapy20062681069107716863483
   PubMed Web of Science ®Google Scholar
• YuKSChoJYJangIJEffect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesClin Pharmacol Ther200476210411215289787
   PubMed Web of Science ®Google Scholar
• YangJWLiaoSSZhuLQPopulation pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantationInt J Clin Pharmacol Ther2015531758325207550
   PubMed Web of Science ®Google Scholar
• ZhuLYangJZhangYJingYZhangYLiGEffects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patientsXenobiotica201545984084625869250
   PubMed Web of Science ®Google Scholar
• DutkowskiPde RougemontOMüllhauptBClavienPACurrent and future trends in liver transplantation in EuropeGastroenterology20101383e804802809
   Web of Science ®Google Scholar
• IngulliEMechanism of cellular rejection in transplantationPediatr Nephrol2010251617421476231
   PubMed Web of Science ®Google Scholar
• FukudoMYanoIFukatsuSForecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantationClin Pharmacokinet200342131161117814531726
   PubMed Web of Science ®Google Scholar
• LiDLuWZhuJYGaoJLouYQZhangGLPopulation pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patientsJ Clin Pharm Ther200732550551517875118
   PubMed Web of Science ®Google Scholar
• ChenBShiHQLiuXXPopulation pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patientsJ Clin Pharm Ther201742667968828833329
   PubMed Web of Science ®Google Scholar
• FukudoMYanoIYoshimuraAImpact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patientsPharmacogenet Genomics200818541342318408564
   PubMed Web of Science ®Google Scholar
• SchianoTDKim-SchlugerLGondolesiGMillerCMAdult living donor liver transplantation: the hepatologist’s perspectiveHepatology20013313911124813
   PubMed Web of Science ®Google Scholar
• AntignacMHulotJSBoleslawskiEPopulation pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the postoperative clearanceEur J Clin Pharmacol2005615–640941615991041
   PubMed Web of Science ®Google Scholar
• FukatsuSYanoIIgarashiTPopulation pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantationEur J Clin Pharmacol2001576–747948411699612
   PubMed Web of Science ®Google Scholar
• Macchi-AndansonMCharpiatBJelliffeRWDucerfCFourcadeNBaulieuxJFailure of traditional trough levels to predict tacrolimus concentrationsTher Drug Monit200123212913311294512
   PubMed Web of Science ®Google Scholar
• OteoILukasJCLealNTacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian predictionEur J Clin Pharmacol20136916574
   PubMed Web of Science ®Google Scholar
• ValdiviesoNOteoIValdiviesoATacrolimus dose individualization in “de novo” patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiologyInt J Clin Pharmacol Ther201351760661423735178
   PubMed Web of Science ®Google Scholar
• MoesDJvan der BentSASwenJJPopulation pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipientsEur J Clin Pharmacol201672216317426521259
   PubMed Web of Science ®Google Scholar
• AllowayRRDupuisRGabardiSEvolution of the role of the transplant pharmacist on the multidisciplinary transplant teamAm J Transplant20111181576158321672154
   PubMed Web of Science ®Google Scholar
• Organ Procurement and Transplantation Network and Scientific Registry of Transplant RecipientsOPTN/SRTR 2012 Annual Data ReportRockville, MDDepartment of Health and Human Services, Health Resources and Services Administration Healthcare Systems Bureau, Division of Transplantation2014
   Google Scholar
• Korean Society of Health-System Pharmacists (KSHP)Guide For Pharmacy SpecialistsSeoul, KoreaKorean Society of Health-System Pharmacists2015
   Google Scholar